Fuji Pharma Acquires DKSH's OICL
News: Japanese drugmaker Fuji Pharma signed an agreement with Swiss trading company DKSH on August 6 2012 to purchase the OLIC contract manufacturing facility in Thailand. The facility is part of DKSH's business unit healthcare. The purchase of OLIC will enable Fuji Pharma to expand its presence outside Japan, Fuji Pharma's CEO and President Hirofumi Imai said. The acquisition worth US$53mn will add a bestin-class contract manufacturing business to Fuji Pharma's portfolio, Imai added.